Patient Guide: Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 41 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06106308
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation
Phase: PHASE2

Find a Study Location Near You

This study is available at 41 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Phoenix, Arizona
  • Tucson, Arizona
  • Jonesboro, Arkansas
  • • And 38 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily